HY-138632-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
HY-138632-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
HY-P9998-1mg
|
MedChemexpress LLC
|
Semzuvolimab [CAS 2409099-32-5]
|
|
Cancer-programmed cell death
|
|
HY-P9998-10mg
|
MedChemexpress LLC
|
Semzuvolimab [CAS 2409099-32-5]
|
|
Cancer-programmed cell death
|
|
HY-P9998-5mg
|
MedChemexpress LLC
|
Semzuvolimab [CAS 2409099-32-5]
|
|
Cancer-programmed cell death
|
|
HY-D1375-10mg
|
MedChemexpress LLC
|
Sulfo-Cy5 amine [CAS 2183440-44-8]
|
|
|
|
HY-D1375-5mg
|
MedChemexpress LLC
|
Sulfo-Cy5 amine [CAS 2183440-44-8]
|
|
|
|
HY-102001-10mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
HY-102001-25mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
HY-102001-5mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
HY-102001-50mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
HY-P99470-1mg
|
MedChemexpress LLC
|
Benufutamab [CAS 2109730-69-8]
|
|
Cancer-programmed cell death
|
|
HY-P99470-10mg
|
MedChemexpress LLC
|
Benufutamab [CAS 2109730-69-8]
|
|
Cancer-programmed cell death
|
|
HY-P99470-5mg
|
MedChemexpress LLC
|
Benufutamab [CAS 2109730-69-8]
|
|
Cancer-programmed cell death
|
|
HY-153235-500ug
|
MedChemexpress LLC
|
COVID-19 Spike Protein mRNA-LNP
|
|
|
|
HY-134669-10mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-100mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-25mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-5mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-50mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-100mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-25mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-250mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-50mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-P99175-1mg
|
MedChemexpress LLC
|
KWAR 23 [CAS 2243227-60-1]
|
|
Cancer-programmed cell death
|
|